Abstract Details Title Comparability of Randomized Controlled Versus Observational Studies: Findings from the Toronto Observational Study of Natalizumab in Multiple Sclerosis Topic MS and Related Diseases Presentation(s) (-) Poster/Presentation Number 071 Objective Background Design/Methods Results Conclusions Authors/Disclosures No disclosure on file